 Current ISLHD Research Papers 

A collection of newly published research by current ISLHD staff. 

• Presgrave P; et.al. (2023, February 21). Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study. Hemasphere. 2023 Feb 21;7(3):e836. doi: 10.1097/HS9.0000000000000836

• Lee A; et.al.(2023, February 17). Correction: Clinical predictors and management for radial artery spasm: an Australian cross‑sectional study. BMC Cardiovasc Disord. 2023 Feb 17;23(1):90. doi: 10.1186/s12872-023-03119-9 

• Brown K; et.al. (2023, February 8). Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW). Clin Infect Dis. 2023 Feb 8;76(3):e622-e628. doi: 10.1093/cid/ciac660.

• Sandell T;Miller A;Vijayakumar V;Dinh L; et.al. (2023, February 7). Patient self-reported follow-up for radiation oncology patients during COVID-19: feasibility and patient-clinician agreement. Journal of Radiation Oncology Informatics, 12(2). doi.org/10.5166/jroi.12.2.1

• Sarkis LM;Jones AC;MacKay SG; et.al. (2023, February 1). Australasian Sleep Association position statement on consensus and evidence based treatment for primary snoring. Respirology. 2023 Feb;28(2):110-119. doi: 10.1111/resp.14443.

• Norman J;Budgen P;Callahan H; et.al. (2023, February 1). Feasibility, acceptability and potential efficacy of a virtual physical activity program in primary and secondary schools in New South Wales, Australia: A quasi-experimental study. Health Promot J Austr. 2023 Feb;34(1):70-84. doi: 10.1002/hpja.662.

• Waller K;Furber S; et. al. (2023, February 1). Acceptability, feasibility and preliminary impact evaluation of a pilot text-message study on improving the health of Aboriginal people with, or at risk of, chronic disease in Australia. Health Promot J Austr. 2023 Feb;34(1):24-29. doi: 10.1002/hpja.676.

• Pai N; et.al. (2023, February 1). Persistence and adherence to second-generation antipsychotic long-acting injectable medications for schizophrenia: A comparative study in the Australian context. Australas Psychiatry. 2023 Feb;31(1):76-81. doi: 10.1177/10398562221142453

• Devoy T;Hunter M;Smith NA. (2023, February 1). A prospective observational study of the effects of sugammadex on peri-operative oestrogen and progesterone levels in women who take hormonal contraception. Anaesthesia. 2023 Feb;78(2):180-187. doi: 10.1111/anae.15902.

• Deen R;Sia ZK. (2023, February 1). Review article: Acute superior mesenteric vessel ischaemia: A review of clinical practice and biomarkers. Emerg Med Australas. 2023 Feb;35(1):14-17. doi: 10.1111/1742-6723.14145.

• Reid D;Lintzeris N; et.al. (2023, February 1). Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug Alcohol Rev. 2023 Feb;42(2):389-400. doi: 10.1111/dar.13588.

• Chen JHC; et.al. (2023, February 1). Sex Disparity in Cause-Specific and All-Cause Mortality Among Incident Dialysis Patients. Am J Kidney Dis. 2023 Feb;81(2):156-167.e1. doi: 10.1053/j.ajkd.2022.07.007.

• Pullman J; et.al. (2023, February 1). Impact of strengths model training and supervision on the therapeutic practice of Australian mental health clinicians. Int J Ment Health Nurs. 2023 Feb;32(1):236-244. doi: 10.1111/inm.13079.

• Oborn BM; et.al. (2023, February 1). Commissioning a beam line for MR-guided particle therapy assisted by in silico methods. Med Phys. 2023 Feb;50(2):1019-1028. doi: 10.1002/mp.

Show more results